Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP5354 for intraoperative ureter visualization
NCT05754333Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Aug 2023
- Primary completion
- Dec 2024
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of pudexacianinium chloride, sponsored by Astellas Pharma. Started Aug 2023; status: completed.
02
Drugs
pudexacianinium chloride
Beyond the preview
Go deeper on NCT05754333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05754333.